Ono Pharmaceutical is putting AI agents in front of the scientists who run its earliest-stage research. Under a collaboration announced on July 28, 2026, the Osaka drugmaker will deploy Biomni Lab, the agentic research platform built by South San Francisco applied-AI lab Phylo, across its drug discovery organization. What the platform is meant to absorb, according to the announcement, is the full span of a discovery scientist's computational day: synthesizing a program's experimental history… [...]
Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]
Earlier this summer Engadget covered the news that Warner Bros. Discovery would split into two giant media companies. Today the conglomerate announced the names for the restructured entities.<br /& [...]
AI agents – task-specific models designed to operate autonomously or semi-autonomously given instructions — are being widely implemented across enterprises (up to 79% of all surveyed for a PwC rep [...]
Chai Discovery’s $400m raise triples its value to $3.8bn in seven months. It is the latest sign that AI drug discovery has moved from promise to deployment. AI drug discovery just minted another fas [...]
Amazon Web Services on Tuesday launched one of the most consequential enterprise AI plays in the company's 20-year history, simultaneously bringing OpenAI's most powerful models to its Bedro [...]
For the first time on a major AI platform release, security shipped at launch — not bolted on 18 months later. At Nvidia GTC this week, five security vendors announced protection for Nvidia's a [...]
Jensen Huang walked onto the GTC stage Monday wearing his trademark leather jacket and carrying, as it turned out, the blueprints for a new kind of monopoly.The Nvidia CEO unveiled the Agent Toolkit, [...]